Rheumatic Diseases Unit, Ha'Emek MC, Afula, Israel.
Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
Curr Rheumatol Rep. 2021 Jan 26;23(1):6. doi: 10.1007/s11926-020-00972-x.
PURPOSE OF REVIEW: Diffuse Idiopathic Skeletal Hyperostosis (DISH) is considered a metabolic condition, characterized by new bone formation affecting mainly at entheseal sites. Enthesitis and enthesopathies occur not only in the axial skeleton but also at some peripheral sites, and they resemble to some extent the enthesitis that is a cardinal feature in spondyloarthritis (SpA), which is an inflammatory disease. RECENT FINDINGS: We review the possible non-metabolic mechanism such as inflammation that may also be involved at some stage and help promote new bone formation in DISH. We discuss supporting pathogenic mechanisms for a local inflammation at sites typically affected by this disease, and that is also supported by imaging studies that report some similarities between DISH and SpA. Local inflammation, either primary or secondary to metabolic derangements, may contribute to new bone formation in DISH. This new hypothesis is expected to stimulate further research in both the metabolic and inflammatory pathways in order to better understand the mechanisms that lead to new bone formation. This may lead to development of measures that will help in earlier detection and effective management before damage occurs.
目的综述:弥漫性特发性骨肥厚(DISH)被认为是一种代谢性疾病,其特征为主要影响肌腱附着点的新骨形成。肌腱炎和肌腱病不仅发生在中轴骨骼,也发生在一些外周部位,在某种程度上类似于脊柱关节炎(SpA)的特征性肌腱炎,后者是一种炎症性疾病。
最新发现:我们回顾了可能的非代谢机制,如炎症,这些机制可能在某个阶段也会参与其中,并有助于促进 DISH 中的新骨形成。我们讨论了支持在疾病典型受累部位发生局部炎症的发病机制,影像学研究也报告了 DISH 和 SpA 之间的一些相似之处,支持这一观点。局部炎症无论是原发性还是继发于代谢紊乱,都可能导致 DISH 中的新骨形成。这一新假说有望促进对代谢和炎症途径的进一步研究,以更好地了解导致新骨形成的机制。这可能导致开发出有助于在发生损害之前更早发现和有效管理的措施。
Curr Rheumatol Rep. 2021-1-26
RMD Open. 2020-2
Medicina (Kaunas). 2021-9-24
Immunotherapy. 2020-7
Semin Arthritis Rheum. 2024-10
Joint Bone Spine. 2013-5-31
Front Microbiol. 2023-10-27
Annu Rev Pathol. 2024-1-24
Case Rep Radiol. 2023-9-25
Immunotherapy. 2020-7
BMC Musculoskelet Disord. 2018-5-30
Nat Rev Rheumatol. 2017-11-21
Curr Rheumatol Rep. 2017-9